Spring Creek Capital’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-66,666
Closed -$82K 339
2022
Q1
$82K Hold
66,666
﹤0.01% 504
2021
Q4
$113K Buy
+66,666
New +$113K ﹤0.01% 457

Other funds holding HLGN.WS

Spring Creek Capital's HLGN.WS Position: Q2 2022 in Review

Spring Creek Capital sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q2 2022, closing a stake of 66,666 shares — an estimated $82K sold.

Spring Creek Capital first reported a position in HLGN.WS in Q4 2021 and held it in 2 quarters. The position peaked at $113K in Q4 2021. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q2 2022.

  • Spring Creek Capital reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q2 2022 after selling out during the quarter.
  • Spring Creek Capital sold 66,666 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q2 2022, an estimated $82K.
  • Spring Creek Capital first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 2 quarters.
  • Spring Creek Capital's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $113K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.